TNFRSF8 and extranodal nasal NK/T cell lymphoma: While our understanding of this resistance is limited, research in natural killer/T-cell lymphoma (NKTCL) has suggested a role for aberrant JAK-STAT signaling in primary resistance to chidamide, with TNFRSF8 (CD30) as a potential predictive biomarker (34).